The patient, whom Sarepta described as a young man and later told news outlets was 16 years old, suffered acute liver failure ...

Sarepta Therapeutics said on Tuesday that a 16-year-old boy died from acute liver failure months after receiving the company's U.S-approved gene therapy for a rare muscular dystrophy. The patient ...

Canopy is launching a multi-year partnership with Texas Oncology, one of the country’s largest community-based cancer care ...

Cambridge-based Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for ...

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently ...

Titled “State of the Industry—The Evolving Landscape of Healthcare Coverage and Access in 2025,” 1 the goal of the Access USA ...

Leaders with Lutheran Health Network (LHN) introduced a sweet new staff member on Tuesday—a therapy dog named Pepper.

An Ohio court has overturned part of the state’s law banning certain healthcare for transgender youth, allowing patients to again receive prescriptions like ...

Venxxiva ™ (tiopronin delayed-release tablet) has been made available for the treatment of cystinuria.

López-Gil says higher social media use correlates with increased orthorexia symptoms, particularly within online “clean eating” communities. He also pointed to post-pandemic shifts in eating habits, ...

Elevidys was approved after intense debate at the FDA, as officials and reviewers disagreed over how strong the evidence was ...

The young man died of acute liver injury, a known side effect, Sarepta said in a statement. But the company said the ...